Skip to main content
Journal cover image

300P TIME-HER: A dynamic predictive model for prognosis of HER2-positive early breast cancer after HER2-targeted therapy

Conferences
Shang, Q; Wang, X; Luo, S
Published in: Annals of Oncology
September 2025

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Annals of Oncology

DOI

ISSN

0923-7534

Publication Date

September 2025

Volume

36

Start / End Page

S309 / S309

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shang, Q., Wang, X., & Luo, S. (2025). 300P TIME-HER: A dynamic predictive model for prognosis of HER2-positive early breast cancer after HER2-targeted therapy. In Annals of Oncology (Vol. 36, pp. S309–S309). Elsevier BV. https://doi.org/10.1016/j.annonc.2025.08.729
Shang, Q., X. Wang, and S. Luo. “300P TIME-HER: A dynamic predictive model for prognosis of HER2-positive early breast cancer after HER2-targeted therapy.” In Annals of Oncology, 36:S309–S309. Elsevier BV, 2025. https://doi.org/10.1016/j.annonc.2025.08.729.
Shang Q, Wang X, Luo S. 300P TIME-HER: A dynamic predictive model for prognosis of HER2-positive early breast cancer after HER2-targeted therapy. In: Annals of Oncology. Elsevier BV; 2025. p. S309–S309.
Shang, Q., et al. “300P TIME-HER: A dynamic predictive model for prognosis of HER2-positive early breast cancer after HER2-targeted therapy.” Annals of Oncology, vol. 36, Elsevier BV, 2025, pp. S309–S309. Crossref, doi:10.1016/j.annonc.2025.08.729.
Shang Q, Wang X, Luo S. 300P TIME-HER: A dynamic predictive model for prognosis of HER2-positive early breast cancer after HER2-targeted therapy. Annals of Oncology. Elsevier BV; 2025. p. S309–S309.
Journal cover image

Published In

Annals of Oncology

DOI

ISSN

0923-7534

Publication Date

September 2025

Volume

36

Start / End Page

S309 / S309

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences